Form D · Biotechnology

ViroMissile, Inc.

La Jolla, CA · CIK 0001974798

Offering snapshot reported Jun 6, 2025 · SEC filing

Reported sold: $500K
Investors reported: 5
Minimum accepted: $100K
First sale: Mar 12, 2025

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$200,000 → $500,000
Reported investors2 → 5

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Jun 6, 2025	Amendment	$500,000	$300,000vs Apr 22, 2025	5	SEC filing
Apr 22, 2025	Amendment	$200,000	$100,000vs Mar 19, 2025	2	SEC filing
Mar 19, 2025	Initial	$100,000	No comparison	1	SEC filing
Apr 26, 2023	Initial	$50,000	No comparison	1	SEC filing

Offering details

Securities: Equity, Security to be acquired
Exemptions: 06b
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-541398

Source: Form D, filed Jun 6, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Rolf Benirschke	Director
Mark Bertagnolli	Director, Executive
Nanhai G. Chen	Director, Executive
Douglas Wall	Director
Weili Zhou	Director
Tianyu Zhou	Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:

505 Coast Blvd South, Suite 208
La Jolla, CA, 92037